Innovative Pharmaceutical Project Investment

Advanced pharmaceutical start-up based on innovative operating formula. Experienced team of dedicated professionals with the know-how to introduce a new drug formulation to the US market. Initial stage planned and underway to launch drug into lucrative cardiovascular pharma market. Seeking financial or industry investor with capital to continue work on FDA registration of drug formulation. Very large and promising target market size of over $2.5 billion. Patent protection for the next 20 years. A marketing authorization regulatory pathway developed and confirmed by the FDA. The management team is considering debt capital (convertible loan) or an equity investment in exchange for taking a stake in the company. Strategic investor capital or co-development entry is a possibility. The project has raised more than $2 million to date, including from a VC fund.
Capital sought: $2-8 million

Area of origin: USA

Contact us for more details. Please use the form below.